Winner Medical Co Ltd
SZSE:300888
Winner Medical Co Ltd
SZSE:300888
Price:
33.94
CNY
-0.7%
Market Closed
Market Cap:
¥19.8B
Income Statement
Earnings Waterfall
Winner Medical Co Ltd
Winner Medical Co Ltd
Income Statement
Winner Medical Co Ltd
Winner Medical Co Ltd
Currency: CNY
| Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||
| Interest Expense |
0
|
4
|
2
|
2
|
2
|
30
|
8
|
19
|
47
|
50
|
91
|
97
|
85
|
63
|
59
|
55
|
53
|
55
|
59
|
0
|
0
|
|
| Revenue |
10 979
N/A
|
12 534
+14%
|
14 802
+18%
|
12 414
-16%
|
8 831
-29%
|
8 037
-9%
|
8 091
+1%
|
9 135
+13%
|
9 860
+8%
|
11 351
+15%
|
11 381
+0%
|
10 460
-8%
|
9 719
-7%
|
8 185
-16%
|
7 742
-5%
|
7 952
+3%
|
8 245
+4%
|
8 978
+9%
|
9 674
+8%
|
10 241
+6%
|
10 805
+6%
|
|
| Gross Profit | ||||||||||||||||||||||
| Cost of Revenue |
(4 392)
|
(5 212)
|
(6 237)
|
(5 341)
|
(4 568)
|
(4 121)
|
(4 275)
|
(4 820)
|
(5 133)
|
(6 305)
|
(6 012)
|
(5 498)
|
(5 067)
|
(4 365)
|
(4 085)
|
(4 237)
|
(4 396)
|
(4 873)
|
(5 159)
|
(5 488)
|
(5 759)
|
|
| Gross Profit |
6 587
N/A
|
7 322
+11%
|
8 565
+17%
|
7 073
-17%
|
4 262
-40%
|
3 916
-8%
|
3 817
-3%
|
4 315
+13%
|
4 727
+10%
|
5 047
+7%
|
5 369
+6%
|
4 962
-8%
|
4 652
-6%
|
3 820
-18%
|
3 657
-4%
|
3 714
+2%
|
3 849
+4%
|
4 105
+7%
|
4 515
+10%
|
4 753
+5%
|
5 046
+6%
|
|
| Operating Income | ||||||||||||||||||||||
| Operating Expenses |
(2 646)
|
(2 507)
|
(3 300)
|
(2 748)
|
(2 193)
|
(2 706)
|
(2 784)
|
(3 018)
|
(3 373)
|
(3 253)
|
(3 602)
|
(3 444)
|
(3 421)
|
(3 071)
|
(3 302)
|
(3 433)
|
(3 464)
|
(3 277)
|
(3 632)
|
(3 786)
|
(3 957)
|
|
| Selling, General & Administrative |
(2 204)
|
(2 032)
|
(2 601)
|
(2 225)
|
(1 832)
|
(2 212)
|
(2 498)
|
(2 603)
|
(2 867)
|
(2 460)
|
(2 758)
|
(2 712)
|
(2 747)
|
(2 444)
|
(2 797)
|
(2 906)
|
(2 955)
|
(2 590)
|
(3 104)
|
(3 267)
|
(3 431)
|
|
| Research & Development |
(385)
|
(387)
|
(511)
|
(432)
|
(341)
|
(283)
|
(293)
|
(347)
|
(401)
|
(467)
|
(504)
|
(444)
|
(382)
|
(301)
|
(287)
|
(271)
|
(285)
|
(327)
|
(364)
|
(399)
|
(408)
|
|
| Depreciation & Amortization |
0
|
(157)
|
0
|
0
|
0
|
(314)
|
0
|
0
|
0
|
(408)
|
0
|
0
|
0
|
(423)
|
0
|
0
|
0
|
(448)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
(57)
|
69
|
(188)
|
(91)
|
(21)
|
101
|
7
|
(69)
|
(105)
|
81
|
(340)
|
(288)
|
(292)
|
97
|
(218)
|
(257)
|
(224)
|
88
|
(163)
|
(120)
|
(118)
|
|
| Operating Income |
3 941
N/A
|
4 815
+22%
|
5 265
+9%
|
4 325
-18%
|
2 069
-52%
|
1 210
-42%
|
1 032
-15%
|
1 297
+26%
|
1 354
+4%
|
1 793
+32%
|
1 767
-2%
|
1 519
-14%
|
1 231
-19%
|
749
-39%
|
355
-53%
|
281
-21%
|
385
+37%
|
827
+115%
|
883
+7%
|
966
+9%
|
1 090
+13%
|
|
| Pre-Tax Income | ||||||||||||||||||||||
| Interest Income Expense |
(79)
|
(184)
|
(157)
|
(99)
|
39
|
270
|
288
|
315
|
327
|
210
|
235
|
218
|
213
|
237
|
203
|
162
|
126
|
179
|
140
|
129
|
104
|
|
| Non-Reccuring Items |
0
|
(125)
|
0
|
(0)
|
(0)
|
(17)
|
3
|
3
|
2
|
(70)
|
4
|
10
|
1 606
|
(247)
|
33
|
29
|
(1 567)
|
(99)
|
5
|
5
|
3
|
|
| Total Other Income |
(16)
|
(3)
|
(38)
|
(27)
|
(31)
|
(1)
|
(7)
|
(13)
|
(15)
|
(13)
|
(53)
|
(49)
|
(46)
|
11
|
(71)
|
(70)
|
(67)
|
1
|
(10)
|
(20)
|
(20)
|
|
| Pre-Tax Income |
3 847
N/A
|
4 502
+17%
|
5 070
+13%
|
4 198
-17%
|
2 076
-51%
|
1 463
-30%
|
1 316
-10%
|
1 602
+22%
|
1 668
+4%
|
1 920
+15%
|
1 952
+2%
|
1 697
-13%
|
3 004
+77%
|
750
-75%
|
520
-31%
|
402
-23%
|
(1 123)
N/A
|
908
N/A
|
1 019
+12%
|
1 081
+6%
|
1 176
+9%
|
|
| Net Income | ||||||||||||||||||||||
| Tax Provision |
(542)
|
(680)
|
(767)
|
(650)
|
(313)
|
(225)
|
(201)
|
(228)
|
(268)
|
(245)
|
(248)
|
(215)
|
(411)
|
(121)
|
(86)
|
(74)
|
152
|
(168)
|
(210)
|
(228)
|
(247)
|
|
| Income from Continuing Operations |
3 305
|
3 823
|
4 303
|
3 549
|
1 764
|
1 237
|
1 114
|
1 374
|
1 400
|
1 674
|
1 705
|
1 483
|
2 593
|
629
|
434
|
329
|
(971)
|
741
|
809
|
853
|
929
|
|
| Income to Minority Interest |
(13)
|
(12)
|
(12)
|
(10)
|
1
|
2
|
2
|
(3)
|
(15)
|
(24)
|
(34)
|
(43)
|
(45)
|
(48)
|
(48)
|
(46)
|
(43)
|
(45)
|
(47)
|
(49)
|
(55)
|
|
| Net Income (Common) |
3 292
N/A
|
3 810
+16%
|
4 291
+13%
|
3 539
-18%
|
1 764
-50%
|
1 239
-30%
|
1 116
-10%
|
1 371
+23%
|
1 386
+1%
|
1 651
+19%
|
1 670
+1%
|
1 439
-14%
|
2 548
+77%
|
580
-77%
|
386
-34%
|
283
-27%
|
(1 014)
N/A
|
695
N/A
|
762
+10%
|
803
+5%
|
874
+9%
|
|
| EPS (Diluted) |
8.75
N/A
|
9.79
+12%
|
10.05
+3%
|
8.29
-18%
|
4.13
-50%
|
2.08
-50%
|
2.62
+26%
|
3.28
+25%
|
2.35
-28%
|
2.79
+19%
|
2.84
+2%
|
2.43
-14%
|
4.31
+77%
|
0.98
-77%
|
0.65
-34%
|
0.48
-26%
|
-1.75
N/A
|
1.19
N/A
|
1.31
+10%
|
1.38
+5%
|
1.5
+9%
|
|
Switch to:
Switch to:
See Also
Discover More
